Mental disorders in patients with psoriatic arthritis
A. B. Borisova,
D. Yu. Veltishchev,
T. V. Korotaeva,
P. O. Tremaskina,
L. D. Vorobyova,
E. L. Nasonov https://doi.org/10.47360/1995-4484-2026-39-45
Abstract
Psoriatic arthritis is a chronic, progressive, heterogeneous disease that includes peripheral arthritis and spondyloarthritis, associated with cutaneous psoriasis and affecting various body systems. In addition to its impact on physical health, psoriatic arthritis is interconnected with mental disorders. Inflammatory processes, chronic pain, and other comorbid somatic conditions significantly contribute to the development of mental disorders, primarily depressive and anxiety disorders. Mental disorders often precede and accompany psoriatic arthritis, negatively influencing the severity, disease progression, and treatment efficacy, promoting the development of therapeutic resistance.
About the Authors
A. B. Borisova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Anastasia B. Borisova
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
D. Yu. Veltishchev
V.A. Nasonova Research Institute of Rheumatology ; N.I. Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Dmitry Yu. Veltishchev
115522, Moscow, Kashirskoye Highway, 34A
117997, Moscow, Ostrovitianova str., 1
Competing Interests:
None
T. V. Korotaeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Tatiana V. Korotaeva
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
P. O. Tremaskina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Polina O. Tremaskina
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
L. D. Vorobyova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Lyubov D. Vorobyova
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
E. L. Nasonov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Evgeny L. Nasonov
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
References
1. Mathew AJ, Chandran V. Depression in psoriatic arthritis: Dimensional aspects and link with systemic inflammation. Rheumatol Ther. 2020;7(2):287-300. doi: 10.1007/s40744-020-00207-6
2. Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(6):1481-1488. doi: 10.1016/j.semarthrit.2020.02.001
3. Goel N, Wallace EB, Lindsay C. Hot topics: Depression in individuals with psoriasis and psoriatic arthritis. J Rheumatol. 2024;51(Suppl 2):43-50. doi: 10.3899/jrheum.2024-0362
4. Korsakova YuL, Korotaeva TV, Loginova EYu, Gubar EE, Vasilenko EA, Vasilenko AA, et al. The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(3):275-281 (In Russ.). doi: 10.47360/1995-4484-2021-275-281
5. Carvalho AF, Machado MO, Mallia E, Liu X, Eder L, Solmi M, et al. The association between schizophrenia spectrum disorders and psoriasis: A large-scale population-based case-control study. Br J Dermatol. 2021;185(2):443-445. doi: 10.1111/bjd.20094
6. Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217-225. doi: 10.1007/s10067-019-04734-8
7. Lada G, Chinoy H, Heal C, Warren RB, Talbot PS, Kleyn CE. Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis: A cross-sectional study in a tertiary setting. J Acad Consult Liaison Psychiatry. 2022;63(4):372-383. doi: 10.1016/j.jaclp.2021.12.007
8. Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017;56(6): 907-911. doi: 10.1093/rheumatology/kew502
9. Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31(7):1168-1175. doi: 10.1111/jdv.14175
10. Wang Y, Wang X, Gu X, Pan J, Ouyang Z, Lin W, et al. Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals. J Affect Disord. 2023;337:27-36. doi: 10.1016/j.jad.2023.05.059
11. Lewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG, et al. Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: A population-based study. J Invest Dermatol. 2017;137(4):828- 835. doi: 10.1016/j.jid.2016.11.032
12. Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE. Associations between psoriatic arthritis and mental health among patients with psoriasis: A replication and extension study using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Skin Health Dis. 2022;2(4):e149. doi: 10.1002/ski2.149
13. Lai TL, Au CK, Chung HY, Lau CS. Depression in psoriatic arthritis: Related to socio-demographics, comorbid loads or disease activity? Int J Rheum Dis. 2022;25(4):474-480. doi: 10.1111/1756-185X.14298
14. Tabra SA, abd Elghany SE, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: Relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022;41(11):3391-3399. doi: 10.1007/s10067-022-06300-1
15. Filimonova OG, Simonova OV. Quality of life and psycho-emotional status of patients with psoriatic arthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2009;47(3):25-28 (In Russ.).
16. Lisitsyna TA, Veltishchev DYu, Nasonov EL, Lila AM. Psychiatric aspects of spondyloarthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(6):716-724 (In Russ.). doi: 10.47360/1995-4484-2020-716-724
17. Zafiriou E, Daponte AI, Siokas V, Tsigalou C, Dardiotis E, Bogdanos DP. Depression and obesity in patients with psoriasis and psoriatic arthritis: Is IL-17-mediated immune dysregulation the connecting link? Front Immunol. 2021;12:699848. doi: 10.3389/fimmu.2021.699848
18. De Lorenzis E, Natalello G, Bruno D, Tanti G, Magurano MR, Lucchetti D, et al. Psoriatic arthritis and depressive symptoms: Does systemic inflammation play a role? Clin Rheumatol. 2021;40(5):1893-1902. doi: 10.1007/s10067-020-05417-5
19. Wang X, Wu L, Liu J, Ma C, Liu J, Zhang Q. The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions. Biomed Pharmacother. 2025;182:117802. doi: 10.1016/j.biopha.2024.117802
20. Waszczak-Jeka M, Żuchowski P, Dura M, Bielewicz-Zielińska A, Kułakowski M, Góralczyk A. Interleukin levels and depressive symptoms in psoriatic arthritis patients: Insights from a case-control study on socio-demographic factors and disease perception. Rheumatol Int. 2024;44(7):1337-1343. doi: 10.1007/s00296-024-05599-0
21. Lisitsina TA, Veltishchev DYu, Krasnov VN, Nasonov EL. Clinical and pathogenetic relationships between immuno-inflammatory rheumatic diseases and psychic disorders. Clinical Medicine. 2014;(1):12-20 (In Russ.).
22. Chaudhary R, Prasad A, Agarwal V, Rehman M, Kumar A, Kaushik AS, et al. Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol. 2023;125(Pt A):111046. doi: 10.1016/j.intimp.2023.111046
23. Alekseeva SA. Predisposing role of childhood mental trauma in immunoinflammatory rheumatic diseases and mental disorders. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2022;60(4):438- 444 (In Russ.). doi: 10.47360/1995-4484-2022-438-444
24. McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, et al. Depression and anxiety in psoriatic disease: Prevalence and associated factors. J Rheumatol. 2014;41(5):887-896. doi: 10.3899/jrheum.130797
25. Salihoglu S, Dogan SC, Kavakci O. Effects of childhood psychological trauma on rheumatic diseases. Eur J Rheumatol. 2019;6(3):126-129. doi: 10.5152/eurjrheum.2019.18184
26. Sun Y, Li Y, Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022;12(1):20526. doi: 10.1038/s41598-022-24872-5
27. Freuer D, Linseisen J, Meisinger C. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis. JAMA Dermatol. 2022;158(11):1262-1268. doi: 10.1001/jamadermatol.2022.3682
28. Weijers JM, Müskens WD, Van Riel PLCM. Effect of significant weight loss on disease activity: Reason to implement this nonpharmaceutical intervention in daily clinical practice. RMD Open. 2021;7(1):e001498. doi: 10.1136/rmdopen-2020-001498
29. Ishchenko A, Pazmino S, Neerinckx B, Lories R, de Vlam K. Comorbidities in early psoriatic arthritis: Data from the metabolic disturbances in psoriatic arthritis cohort study. Arthritis Care Res (Hoboken). 2024;76(2):231-240. doi: 10.1002/acr.25230
30. Moroni L, Farina N, Dagna L. Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol. 2020;39(4):1039-1047. doi: 10.1007/s10067-020-04963-2
31. Valero-Jaimes JA, López-González R, Martín-Martínez MA, García-Gómez C, Sánchez-Alonso F, Sánchez-Costa JT, et al. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the Cardiovascular in Rheumatology (Carma) project. J Clin Med. 2021;10(3):382. doi: 10.3390/jcm10030382
32. Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, et al. Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: A clinical cohort study. Rheumatology (Oxford). 2021;60(7):3289-3300. doi: 10.1093/rheumatology/keaa780
33. Moradi Y, Albatineh AN, Mahmoodi H, Gheshlagh RG. The relationship between depression and risk of metabolic syndrome: A meta-analysis of observational studies. Clin Diabetes Endocrinol. 2021;7(1):4. doi: 10.1186/s40842-021-00117-8
34. Al-Khatib Y, Akhtar MA, Kanawati MA, Mucheke R, Mahfouz M, Al-Nufoury M. Depression and metabolic syndrome: A narrative review. Cureus. 2022;14(2):e22153. doi: 10.7759/cureus.22153
35. Lamers F, Milaneschi Y, Vinkers CH, Schoevers RA, Giltay EJ, Penninx BWJH. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav Immun. 2020;88:174-183. doi: 10.1016/j.bbi.2020.04.002
36. Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: A bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11(1):633. doi: 10.1038/s41398-021-01759-z
37. Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic low-grade inflammation and its markers. Cureus. 2022;14(2):e22711. doi: 10.7759/cureus.22711
38. Carvalho LM, Carvalho BG, Souza LL, da Mota JC, Ribeiro AA, Nicoletti CF. Obesity as an aggravating factor of systemic lupus erythematosus disease: What we already know and what we must explore. A rapid scoping review. Nutrition. 2024;128:112559. doi: 10.1016/j.nut.2024.112559
39. Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, SánchezMargalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21(16):5887. doi: 10.3390/ijms21165887
40. Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front Physiol. 2020;11:578966. doi: 10.3389/fphys.2020.578966
41. Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis. 2019;22(6):967-973. doi: 10.1111/1756-185X.13553
42. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31-41. doi: 10.1001/2013.jamapsychiatry.4
43. Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: A meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016;21(5):642-649. doi: 10.1038/mp.2015.67
44. Sood A, Raji MA. Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying antirheumatic drugs. Clin Rheumatol. 2021;40(4):1221-1231. doi: 10.1007/s10067-020-05372-1
45. Schiweck C, Aichholzer M, Reif A, Edwin Thanarajah S. Targeting IL-17A signaling in suicidality, promise or the long arm of coincidence? Evidence in psychiatric populations revisited. J Affect Disord Rep. 2023;11:100454. doi: 10.1016/j.jadr.2022.100454
46. Karateev АЕ, Polishchuk ЕYu, Dubinina ТV. Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2024;62(2):154-161 (In Russ.). doi: 10.47360/1995-4484-2024-154-161
47. Gialouri CG, Evangelatos G, Zhao SS, Kouna K, Karamanakos A, Iliopoulos A, et al. Depression and anxiety in a real-world psoriatic arthritis longitudinal study: Should we focus more on patients’ perception? Clin Exp Rheumatol. 2023;41(1):159-165. doi: 10.55563/clinexprheumatol/8qxo80
48. Akulinushkina EYu, Yakupova SP, Yakupov EZ, Ivanova LV, Bragina TA, Maksimov NI. Central sensitization in psoriatic arthritis. Bulletin of Contemporary Clinical Medicine. 2023;16:16-21 (In Russ.). doi: 10.20969/VSKM.2023.16(5).16-21
49. Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary mania induced by TNF-α inhibitors: A systematic review. Psychiatry Clin Neurosci. 2022;76(1):15-21. doi: 10.1111/pcn.13302
50. Lada G. Immune links in comorbid depression and psoriasis: A narrative mini-review and perspective. Brain Behav Immun Health. 2025;44:100949. doi: 10.1016/j.bbih.2025.100949
51. Ribeiro AL, Singla S, Chandran V, Chronis N, Liao W, Lindsay C, et al. Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): A GRAPPA perspective from an international survey of healthcare professionals. Rheumatol Adv Pract. 2024;8(3):rkae074. doi: 10.1093/rap/rkae074
52. Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430-1434. doi: 10.1002/acr.24593
53. Martins A, Oliveira D, Nicolau R, Rocha TM, Bernardo A, Costa L, et al. What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs? Clin Rheumatol. 2024;43(1):251-258. doi: 10.1007/s10067-023-06806-2
54. Haugeberg G, Hoff M, Kavanaugh A, Michelsen B. Psoriatic arthritis: Exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates. Arthritis Res Ther. 2020;22(1):198. doi: 10.1186/s13075-020-02294-w
55. Bell KA, Balogh EA, Feldman SR. An update on the impact of depression on the treatment of psoriasis. Expert Opin Pharmacother. 2021;22(6):695-703. doi: 10.1080/14656566.2020.1849141
56. Türk İ, Aşık MA, Acemoğlu ŞŞZ, Varkal G, Ünal İ. Fibromyalgia and associated factors in patients with axial spondyloarthritis: The effect of fibromyalgia on disease activity. Revista Colombiana de Reumatologia. 2024;31(2):159-165. doi: 10.1016/j.rcreu.2022.10.001
57. Toledano E, Hidalgo C, Gómez-Lechón L, Ibáñez M, Chacón CC, Martín-Vallejo J, et al. SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: A cross-sectional study. Sci Rep. 2023;13(1): 22927. doi: 10.1038/s41598-023-48723-z
58. Ketenci S, Uzuner B, Bilgici A. Comparison of quality of life, depression and fatigue in patients with psoriasis and psoriatic arthritis. J Experim Clin Med (Turkey). 2022;39(1):174-179. doi: 10.52142/omujecm.39.1.35
59. Nymand L, Kristensen LE, Thomsen SF, Thyssen JP, Egeberg A. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study. J Am Acad Dermatol. 2024;91(1):57-63. doi: 10.1016/j.jaad.2024.02.026
60. Cajamarca-Barón J, Guavita-Navarro D, Gallego-Cardona L, Buitrago-Bohórquez J, Guevara D, Rivadeneira S, et al. Mood disorders in psoriatic arthritis. Revista Colombiana de Reumatología. 2023;30:S97-S104. doi: 10.1016/J.RCREU.2023.02.013
61. Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, et al. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int. 2023;43(1):89-97. doi: 10.1007/s00296-022-05248-4
62. Garcia LOKL, Júnior ATS, Gómez DCDS, Yoshikawa GSS, Kamikoga CK, Vitturi BK. Cognitive impairment in patients with psoriatic arthritis. Acta Neurol Belg. 2022;122(1):91-96. doi: 10.1007/s13760-021-01644-y
63. Di Carlo M, Becciolini A, Incorvaia A, Beci G, Smerilli G, Biggioggero M, et al. Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors. Medicine (Baltimore). 2021;100(11):e24833. doi: 10.1097/MD.0000000000024833
64. Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: A systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36-43.
Review
For citations:
Borisova A.B., Veltishchev D.Yu., Korotaeva T.V., Tremaskina P.O., Vorobyova L.D., Nasonov E.L. Mental disorders in patients with psoriatic arthritis. Rheumatology Science and Practice. 2026;64(1):39-45. (In Russ.) https://doi.org/10.47360/1995-4484-2026-39-45
Views:
180
JATS XML
Email this article 